Those market caps are unrealistic with the cash we have and are able to generate currently with Avid. There would need to be some type of partnership or collaberation with a legitimate pharma, with upfront cash. Hopefully that happens this year.
On a different topic, I think the company knows what they need to do to get the Going Concern clause removed and will get it done this year. That is about cash also. They sold enough shares to get the cash necessary.
Market Data 
Markets 
AI
